These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6604561

  • 1. Hypnotic effects of deoxycorformycin in rats.
    Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD.
    Brain Res; 1983 Jul 25; 271(2):392-5. PubMed ID: 6604561
    [Abstract] [Full Text] [Related]

  • 2. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM, Belch A, Henderson JF.
    Biochem Pharmacol; 1980 Apr 15; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP.
    Biochem Pharmacol; 1980 Feb 15; 29(2):187-93. PubMed ID: 6965857
    [No Abstract] [Full Text] [Related]

  • 5. Effects of pentostatin (2'deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats.
    Gilbertsen RB.
    J Immunopharmacol; 1985 Feb 15; 7(3):325-41. PubMed ID: 3877119
    [Abstract] [Full Text] [Related]

  • 6. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE, Dawicki DD, Agarwal KC, Chen SF, Stoeckler JD.
    Ann N Y Acad Sci; 1985 Feb 15; 451():188-203. PubMed ID: 3878117
    [No Abstract] [Full Text] [Related]

  • 7. Adenosine and hypoxic vasodilatation.
    Dóra E.
    J Cereb Blood Flow Metab; 1985 Dec 15; 5(4):621-4. PubMed ID: 3877069
    [No Abstract] [Full Text] [Related]

  • 8. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM, Henderson JF.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1545-51. PubMed ID: 6980005
    [Abstract] [Full Text] [Related]

  • 9. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H, Thorbecke GJ, Hirschhorn R.
    Clin Immunol Immunopathol; 1981 Oct 15; 21(1):119-27. PubMed ID: 6268339
    [No Abstract] [Full Text] [Related]

  • 10. Role of adenosine in sleep in rats.
    Radulovacki M.
    Rev Clin Basic Pharm; 1985 Oct 15; 5(3-4):327-39. PubMed ID: 3916307
    [Abstract] [Full Text] [Related]

  • 11. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS, Plunkett W.
    Biochem Pharmacol; 1982 Jun 01; 31(11):2103-9. PubMed ID: 6180754
    [No Abstract] [Full Text] [Related]

  • 12. Transition-state stabilization by adenosine deaminase: structural studies of its inhibitory complex with deoxycoformycin.
    Frick L, Wolfenden R, Smal E, Baker DC.
    Biochemistry; 1986 Apr 08; 25(7):1616-21. PubMed ID: 3486673
    [Abstract] [Full Text] [Related]

  • 13. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA, Thuillier L, Hamet M, Garreau F, Moncion A, Pérignon JL.
    Clin Chim Acta; 1986 Apr 15; 156(1):61-9. PubMed ID: 3486057
    [Abstract] [Full Text] [Related]

  • 14. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW.
    Adv Exp Med Biol; 1986 Apr 15; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract] [Full Text] [Related]

  • 15. Effects of adenosine deaminase inhibitor 2'-deoxycoformycin on the repair and expression of potentially lethal damage sensitive to beta-araA.
    Iliakis G, Ngo FQ.
    Radiat Environ Biophys; 1985 Apr 15; 24(2):81-8. PubMed ID: 3874406
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
    Geiger JD, Lewis JL, MacIntyre CJ, Nagy JI.
    Neuropharmacology; 1987 Sep 15; 26(9):1383-7. PubMed ID: 3499581
    [Abstract] [Full Text] [Related]

  • 17. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB, Begleiter A, Pugh L, Leith MK, Wilkins JA, Cavers DJ, Israels LG.
    Cancer Res; 1986 Apr 15; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [Abstract] [Full Text] [Related]

  • 18. Selective immunotoxic effects in mice treated with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Luebke RW, Lawson LD, Rogers RR, Riddle MM, Rowe DG, Smialowicz RJ.
    Immunopharmacology; 1987 Feb 15; 13(1):25-35. PubMed ID: 2952620
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of PHA and NaI04 mitogenesis by the adenosine deaminase inhibitors erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and 2-deoxycoformycin (2-dCF).
    Lum CT, Sutherland DE, Najarian JS.
    Clin Immunol Immunopathol; 1979 Apr 15; 12(4):453-9. PubMed ID: 222523
    [No Abstract] [Full Text] [Related]

  • 20. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF, Mitchell BS, Koller CA, Coleman MS, Hutton JJ.
    Proc Natl Acad Sci U S A; 1980 Oct 15; 77(10):6157-61. PubMed ID: 6969403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.